Renal Impairment in Hepatorenal Syndrome
1 clinical trials · Condition
◉ Watch Renal Impairment in Hepatorenal Syndrome
| Record | Firm | Date |
|---|---|---|
| Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1. (NCT03455322) | National Hepatology & Tropical Medicine Research Institute | 2018-08-15 |
Track Renal Impairment in Hepatorenal Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.